OSRH · OSR Health, Inc.
$0.25
-0.03 (-9.75%)
At close · Aug 24
View the 10-K filed Mar 31, 2026
Customer concentration
— top 3 customers 95% of revenue
3 customers — 95% of revenue (in recent years)
“Three main customers of RMC have in recent years represented approximately 95% of RMC's total sales.”
Market Cap
$9.73M
Shares
35.12M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.28
Open$0.30
Day$0.27–0.33
52W close$0.28–1.01
Avg vol 30d19.1M
Short int1.0M · 3.0% float · 1.5d
Short vol35%
DataMar 2023–Aug 2026
Filing10-Q · Aug 14
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.1 · calm
Equity put/call 0.51
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−46%
below
Price vs 50-day avg
−28%
below
RSI (14)
41
neutral
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−35%
trailing
6-month return
−32%
trailing
YTD return
−51%
this year
Relative strength
−44%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+7% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.99% of float · ▼ -38.1% MoM · 1.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
29 holders — mid 1-yr range
Squeeze score
36
low risk · 0–100
Fundamentals
Revenue growth
−18%
Y/Y
Gross margin
20%
contracting
EPS growth
+83%
Y/Y
Balance sheet
$813.0K
net debt
Quant / Vol
risk profile
Volatility
189%
annualized · 1-yr
Max drawdown
−73%
past year
ATR
37.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−46%
Bearish
Price vs 50-day avg
−28%
Bearish
RSI (14)
41
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+7% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.99% of float · ▼ -38.1% MoM · 1.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
29 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $1
vs 200-day avg -46%
vs 50-day avg -28%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OSRH
this stock
OSR Health, Inc.
|
$9.73M | -50.9% | -17.7% | — | 3.0% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.91B | +20.9% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.87B | +8.1% | +20.8% | 20.7 | 3.3% |
|
ARGX
Argenx SE
|
$64.66B | +23.6% | — | — | 2.1% |
|
CSLLY
Csl Ltd
|
$57.97B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OSRH | -12.3% | -34.5% | -32.4% | -38.2% | -50.9% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | -11.0% | -38.2% | -44.0% | -40.7% | -63.2% |
Key facts
CIK
1840425
CUSIP
68840D102
13F (30d)
29 filings
29 filers
Visit website
Investor relations